Biosimilars – a Protein-Engineered Biotech Trend for the Future?

25 March 2015

Cambridge Airport, Cambridge

16.45 Welcome from the Host and Chair

17.00 Minimising Therapeutic Antibody Immunogenicity Dr Matthew Baker, CSO, Abzena

17.30 Commercial Considerations for Biosimilar Developers Sahar Shepperd, Associate, Bristows LLP

17.40 Impact of Patent Law on Biosimilars Dominic Adair, Partner, Bristows LLP 18.00 Refreshments and Tour of Terminal

18.30 Q&A Discussion: What Does the Rise of Biosimilars Mean for the Biotech Industry?

19.30 Closing Remarks from the Chair

19.35 Networking, Drinks and Canapes

16.15 Registration

Programme

20.30 Event closes

Speaker Profiles

Dominic Adair, Partner, Bristows LLP Title: Impact of Patent Law on Biosimilars Dominic is a partner at Bristows LLP, specialising in patent litigation. His practice focuses on the life sciences, reflecting his technical background (PhD Zoology, University of Cambridge).

Dominic has extensive experience of cross-border litigation in and beyond Europe and has worked on all aspects of the pharmaceutical product life cycle, from freedom to operate analyses and early-stage risk assessment of generic competition to end-stage litigation, SPCs and anti-trust issues.

Dominic writes regularly on reported patent cases in the UK and at the EPO and is a member of the AIPPI. He is a regular conference speaker and presenter.

Matthew Baker, CSO, Abzena Plc

Title: Minimising Therapeutic Antibody Immunogenicity Dr Baker completed a PhD in cellular immunology at University of Birmingham UK and after completing postdoctoral positions in Cambridge moved into the biotechnology industry where he has held senior management positions at a number of companies including Biovation (subsidiary of Merck KGaA), Cellular Technologies Limited and Whatman BioSciences. Dr Baker is the Chief Scientific Officer of Abzena (part of the PolyTherics group) in Cambridge, UK.

Sahar Shepperd, Associate, Bristows LLP Title: Commercial Considerations for Biosimilar Developers Sahar is an Associate in the IP and commercial transactions department. Prior to joining Bristows, Sahar gained several years of experience in house at Cambridge Antibody Technology (part of the AstraZeneca Group) where she trained and qualified as a Solicitor. Sahar has broad IP experience (both contentious and non-contentious) and advises clients on a range of transactional matters, including technology and product licenses, intellectual property agreements, settlement agreements, clinical trial agreements and research and development agreements.

Matters that Sahar has recently advised on include: - assisting Genomics England in securing the services of Illumina with respect to the

100,000 genome project, the largest of its kind to date; - assisting Locate Therapeutics in securing funding from Heraeus Holdings and

subsequently entering into a licence agreement with Heraeus Medical; - assisting Ariosa Diagnostics in its agreement with UK clinical laboratories; - In-license and purchase of clinical assets in the biotechnology sector; and - setting up multi-site, multi-jurisdictional clinical trials. - Sahar is also a member of the BIA IPAC Committee. Given her strong scientific background and detailed knowledge of the life sciences sector,

Sahar has the expertise necessary to understand both the commercial and technical aspects of intellectual property matters.

Delegate List

Surname First name CompanyAdair Dominic Bristows LLPBach Peter BioPharmaLogic LLCBaker Matthew Abzena PLCBentham Andy J A KempBirrell Graham OCTBlakemore James Cambridge ConsultantsBrowne Ken SELECTBIOButt Neil Abzena PLCCarridge Andrew Reddie & Grose LLPCohen Helen HC Pharma Consultancy LimitedDancer Jane F-star Biotechnology LtdDeal Greer Global Regulatory ServicesDeal Bobby Global Regulatory ServicesGillespie Dee ConsultantHancock Chris George James LtdHill Guy Preome LtdJanuszewski Tadeusz MedImmune LimitedJones Phil F-star Biotechnology LtdJones Tony One NucleusKanabar Pradyp Bio-Analytical Technologies (UK) LimitedKeen Simon Abzena PLCLallement Arthur Retroscreen Virology LtdMcGhee Alison F-star Biotechnology LtdMercer Elizabeth (Liz) Perla Development LtdMichael Adam 80th AtomMurrall Nicholas Consultant - Nick MurrallNess Sam Department of Chemistry, University of Cambridge Nir Dror RadBee LtdNir Rina RadBee LtdNoble Nick Tepnel Pharma ServicesObrezanova Olga Lonza Biologics PlcPostle Martyn Cambridge Healthcare and Biotech LtdRoberts Michael Reddie & Grose LLPRoberts Dave Selcia LimitedShaw Daniel Reddie & Grose LLPShepperd Sahar Bristows LLPShivji Nadia One NucleusSpencer Matthew Boult Wade TennantVelamakanni Saroj Fahy Gurteen LaboratoriesWakes Nicole Abzena PLCWeston-Smith Miranda Consultant